(1)
R. Oladipupo, A.; A. B. Coker, H.; S. Alaribe, C.; D. Okoko, O. Microbial Metabolites and Enzymes Inhibition in Drug Discovery and Development: A Case Study of the Statins, a Class of HMG-CoA Reductase Inhibitors: doi.org 10.26538 Tjnpr V3i4.1. TJNPR 2019, 3, 99-106.